The Science We Fund
We are about one thing: funding the most promising research that will make it from a lab to a child’s bedside in the shortest amount of time possible.
Cookies for Kids’ Cancer has granted over $20 million to date, funding over 100 research projects that have resulted in 25 treatments and clinical trials available to children today.
Our Clinical Trials and Grants Since 2008
2019
| AMOUNT | CENTER | RESEARCHER | GRANT NAME | CATEGORY | TYPE OF CANCER | ||
|
$100,000 |
Seattle's Children Hospital |
Dr. Marie Bleakley |
Immunotherapy for Infant Leukemia - Extension Application |
Blood Cancer |
Blood Cancer |
||
|
$200,000 |
Dana-Farber Cancer Institute |
|
|
Blood Cancer |
Leukemia/ Lymphoma |
||
|
$143,500 |
Children's Oncology Group |
$200,000 |
|||||
|
$150,000 |
Children's Hospital Of Philadelphia |
Dr. Yael Mosse |
Clinical Development of Next Generation ALK inhibitor lorlatinib for patients with ALK-driven neuroblastomas |
Solid and Bone Cancers |
Neuroblastoma |
||
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
| Amount | Center | Researcher | Grant Name | Year | Type of Cancer |
|
$200,000 |
Fred Hutchinson Cancer Research Center |
Dr. Marie Bleakley |
Immunotherapy for Infant Leukemia |
2017 |
Blood Cancer, Leukemia |
|
$200,000 |
UCSF Benioff Children's Hospital |
Dr. Mignon Loh |
Identifying Targeted Therapeutics in Juvenile Myelomonocytic Leukemia |
2017 |
Blood Cancer, Leukemia |
|
$100,000 |
St. Jude Children's Research Hospital |
Dr. Jeffrey Rubnitz |
Pilot study of microtransplantation in pediatric patients with refractory or relapsed acute myeloid leukemia |
2015 |
Blood Cancer, Leukemia |
|
$100,000 |
Children's Hospital of Philadelphia |
Dr. Aplenc |
Chimeric antigen receptor T cell immunotherapy for pediatric acute myeloid leukemia |
2014 |
Blood Cancer, Leukemia |
|
$100,000 |
St. Jude Children's Research Hospital |
Dr. Inaba |
Genetic characterization and therapeutic targeting of pediatric mixed phenotype acute leukemia |
2014 |
|